The most important observation in this study was the significantly lower frequency of 23 TRBV-BD1 sjTRECs in PBMCs, as well as in CD4+ and CD8+ T cells from CML patients as compared with healthy individuals, indicating poor thymic output in CML patients. Here, CD4 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.